Ganessan Kichenadasse

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

Robert L. Coleman, Amit M. Oza, Domenica Lorusso et al. · The Lancet · 2017 · 1.7K citations · Full text

Rucaparib Maintenance Treatment, Medicine, Recurrent Ovarian Carcinoma +7

Secondary Somatic Mutations Restoring <i>RAD51C</i> and <i>RAD51D</i> Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

Olga Kondrashova, Minh Nguyen, Kristy Shield‐Artin et al. · Cancer Discovery · 2017 · 396 citations · Full text

Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non–Small Cell Lung Cancer

Ganessan Kichenadasse, John O. Miners, Arduino A. Mangoni et al. · JAMA Oncology · 2019 · 335 citations · Full text

Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift

Ashley M. Hopkins, Jessica M. Logan, Ganessan Kichenadasse et al. · JNCI Cancer Spectrum · 2023 · 251 citations · Full text

Artificial Intelligence, Chatbot, Engineering +25

Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial

Christopher J. Sweeney, Andrew Martin, Martin R. Stockler et al. · The Lancet Oncology · 2023 · 175 citations

Urology, Oncology, Genitourinary Cancer +7